ANAVEON
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79315746
- Registration number
- 6770173
- Mark type
- Word mark
- Filed
- 11 May 2021
- Published for opposition
- 12 Apr 2022
- Registered
- 28 Jun 2022
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cancer or autoimmune diseases
- Class 035 — Advertising and business services: Advertising
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; industrial research in the field of pharmaceuticals; research and development services in the field of immunology; research and development for the pharmaceutical industry; scientific research services for medical purposes; scientific research for medical purposes in the field of cancerous diseases; scientific research, testing and analysis services; scientific and medical research and development; provision of information relating to medical and scientific research in the field of pharmaceutical products; laboratory research and analysis services
Owner
- Anaveon AG, CH
- Anaveon AG, CH
- Anaveon AG, CH
Prosecution history
- 07 Nov 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Oct 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Oct 2022 — FINAL DISPOSITION PROCESSED
- 28 Sept 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Apr 2022 — PUBLISHED FOR OPPOSITION
- 23 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Mar 2022 — REFUSAL PROCESSED BY IB
- 07 Mar 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Mar 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Mar 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Feb 2022 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB